Cardiovascular Research
Hypertrophic, myotoxic effects of clenbuterol are dose-determined in rat model
Published in Heart Disease Weekly, July 2nd, 2006
According to recent research from England, "Muscle growth in response to large doses (milligrams per kilogram) of beta2 -adrenergic receptor agonists has been reported consistently. However, such doses may also induce myocyte death in the heart and skeletal muscles and hence may not be safe doses for humans."
"We report the hypertrophic and myotoxic effects of different doses of clenbuterol," wrote J.G. Burniston and colleagues at Liverpool John Moores University. "Rats were infused with clenbuterol...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2006-07-02)
More Articles from Heart Disease Weekly
- Cardiovascular Disease
Traumatic thoracic aortic transection repair with adjuvant perfusion reduces paraplegia incidence - Drug Safety
Elevation of myocardial infarction risk is a class effect of COX-2 inhibitors - Myocardial Infarction
Hepatocyte growth factor gene transfer induces artery growth and improves heart function - Surgical Technology
Femoral artery disease treatment with nitinol stent showed superior results to balloon angioplasty - Adverse Drug Reaction
Adverse drug reactions were evaluated in large population of Medicare patients - Anesthesia
General anesthesia for pulmonary embolectomy is often followed by hemodynamic collapse - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
